Turnover: 1.25 billion EUR (2023)
Country: France
Founded in 1968, Virbac specializes in the manufacture of healthcare products, vaccines and pet food.
News
Virbac: innovation strategy and focus on emerging markets 26/08/2024
- - Virbac present in over 100 countries.
- - Virbac employs 5,500 people.
- - Sales by region: 41% in Europe, 17% in Asia-Pacific, 17% in Latin America.
- - Virbac sales in 2023: 1.2 billion euros.
- - Percentage of export sales: 88%.
- - Targeted growth in America and China.
- - Focus on "fast-growing countries" such as India, Indonesia, Egypt, Nigeria and Vietnam.
- - Diversification of species supported: vaccines for tilapia in Asia, Africa and Latin America.
Animal health: Virbac makes an acquisition in Japan 05/04/2024
- - Virbac has acquired Sasaeah, the fourth largest player in the Japanese veterinary market, for 280 million euros.
- - Sasaeah has sales of 75 million euros, 500 employees and production sites in Japan and Vietnam.
- - Vaccines, particularly for farm animals, account for 50% of Sasaeah's portfolio.
- - Virbac also acquired an Indian company specializing in the production of poultry vaccines in November of the previous year.
- - Virbac plans to build a new vaccine production unit in 2027 or 2028 at its Plaine du Var site.
- - Virbac is present in 35 countries, topped the €1 billion sales mark in 2021 and reached €1.25 billion in 2023.
- - The company employs 6,000 people, including 1,350 in Carros.
Virbac is the day's biggest riser on the stock market after raising its annual targets again 19/12/2023
- Virbac's share price has risen by 10%.
- The company's gains since the start of the year stand at around 45%.
- For the year as a whole, Virbac forecasts sales growth of between 4% and 6%
- Globion, an Indian company acquired by Virbac, has sales of around 12 million euros.
- Virnac achieved sales of 1.2 billion euros.
Virbac attracted by dog and cat food 13/10/2022
- Virbac, the world's sixth-largest veterinary laboratory, aims to accelerate its growth in pet nutrition
- construction of a new production unit in Saint-Gilles (Gard), investment €40-50 million
- Pet nutrition currently accounts for just 10% of sales (€1.06 billion last year).
- Most of the business is in care products and medicines, as well as food supplements for farm animals
- In France, the pet food market is estimated at over €5 billion.
- The same region is home to Royal Canin (Mars Group), the world leader with sales of over €4 billion in cat and dog food
Financial Data
DUNS: 417350311
Legal Name: VIRBAC
Address: 1ERE AVENUE LID 2065 M, 06510 CARROS
Number of employees: Entre 1 000 et 1 999 salariés (2020)
Capital: 10 572 500 EUR
Financial Data:
| Year | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|
| Turnover | 381 107 000 | 293 640 000 | 276 149 000 | 266 519 000 | 264 201 000 | 256 691 000 | 271 891 000 |
| Gross margin (€) | 273 727 000 | 206 294 000 | -81 776 000 | 188 584 000 | 186 828 000 | 4 485 804 000 | - |
| EBITDA (€) | 51 743 000 | 20 541 000 | -263 646 000 | 12 713 000 | -10 325 000 | 4 652 124 000 | - |
| Operating profit (€) | 27 696 000 | -2 294 000 | -285 834 000 | -9 560 000 | -14 163 000 | 4 674 660 000 | - |
| Net profit (€) | 68 350 000 | 151 123 000 | 45 057 000 | 36 197 000 | 34 535 000 | 47 678 000 | 39 264 000 |
| Turnover growth rate (%) | 29,8 | 6,3 | 3,6 | 0,9 | 2,9 | -5,6 | - |
| Ebitda margin rate (%) | 13,6 | 7 | -95,5 | 4,8 | -3,9 | 1 812,3 | - |
| Operating margin rate (%) | 7,3 | -0,8 | -103,5 | -3,6 | -5,4 | 1 821,1 | - |
| Working Capital (turnover days) | 100,6 | 88,4 | 206,1 | 214,2 | 183,1 | 130,9 | - |
| Working Capital requirements (turnover days) | 89,2 | 86,9 | 86,5 | 94,8 | 76,5 | 75,7 | - |
| Net margin (%) | 17,9 | 51,5 | 16,3 | 13,6 | 13,1 | 18,6 | - |
| Added value / Turnover (%) | 40,3 | 39,6 | 39,9 | 40,5 | 37,4 | 162,1 | - |
| Wages and social charges (€) | 95 420 000 | 88 163 000 | 88 760 000 | 86 378 000 | 85 413 000 | -84 226 000 | - |
| Salaries / Turnover (%) | 25 | 30 | 32,1 | 32,4 | 32,3 | -32,8 | - |
Company Managers:
| Position | First Name | Last Name | Age | |
|---|---|---|---|---|
| Président du conseil d'administration | Marie Hélène | DICK | 60 | |
| Directeur général | Sébastien Claude Jacques | HURON | 54 | |
| Vice président du conseil d'administration | Pierre | MADELPUECH | 64 | |
| Directeur général délégué | Marc Daniel Jacques | BISTUER | 63 | |
| Directeur général délégué | Habib | RAMDANI | 48 | |
| Administrateur | Philippe Gaston Henri | CAPRON | 66 | |
| Administrateur | Solène Jeanne | MADELPUECH | 31 | |
| Pharmacien responsable | Marc Daniel Jacques | BISTUER | 63 | |
| Administrateur représentant les salariés | Sylvie Marie Cécile | GUEGUEN | 60 |
Studies mentioning this company
The veterinary market - France
Other companies mentioned:
- VetinParis
- Clinique vétérinaire Alliance
- Clinique Vétérinaire des Barques
- CHVE Livet
- CHV Fregis
- Sevetys
- IVC Evidensia France
- Anicura (Mars Petcare)
- Mon Veto
- Vetup
- Vetosoft
- Coveto - MyVet Apps
- Le point vétérinaire
- La dépêche vétérinaire
- Santé Vet - Vetassur
- Dr. Veto /MyVeto
- Vetoquinol
- Virbac
- Centravet groupe - GmVet
- Univet
- Idexx
- Clinique Veterinaire de Bayeux
- Dômes Pharma
- IVC Evidencia
- Animeo
- Tom&co
- Obione